VRSN Form 3: Director Matthew J. Desch Reports 0 Shares
Matthew J. Desch filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to Verisign, Inc. (VRSN) as a Director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Matthew J. Desch filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to Verisign, Inc. (VRSN) as a Director. The event date is 10/06/2025 and the filing is dated 10/08/2025. The form discloses zero shares of common stock beneficially owned and no derivative securities.
Positive
- Director role disclosed for Matthew J. Desch with issuer Verisign (VRSN)
- Form 3 filed documenting the initial beneficial ownership status dated 10/08/2025
Negative
- No common stock reported — 0 shares beneficially owned as of the filing date
- No derivative securities reported, so no disclosed equity-linked compensation at filing
Insights
Initial director disclosure shows appointment without reported equity ownership.
The filing records Matthew J. Desch as a Director of Verisign (VRSN) with an event date of 10/06/2025 and a Form 3 signature dated 10/08/2025. The reported position of 0 common shares and no derivatives indicates no disclosed equity stake at the time of filing.
This creates a clear open data point: future Form 4 filings may show stock grants, purchases, or option awards tied to director compensation. Monitor subsequent Section 16 filings for changes in ownership or standard equity award disclosures within the typical director onboarding period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 3 for VRSN and what is their relationship to the company?
What date triggered the filing and when was the Form 3 signed?
Did the Form 3 report any derivative securities (options, warrants, converts)?
How will investors know if the director receives equity compensation later?
AI-generated analysis. How Rhea-AI works. Not financial advice.